Assetmark, Inc Novartis Ag Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Novartis Ag stock. As of the latest transaction made, Assetmark, Inc holds 223,996 shares of NVS stock, worth $23.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

223,996

Previous 213,706 4.82%

Holding current value

$23.1 Million

Previous $22.8 Million 13.24%

% of portfolio

0.07%

Previous 0.07%

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$106.13 - $120.89 $1.09 Million - $1.24 Million	10,290 Added 4.82%	223,996 $25.8 Million
Q2 2024 Aug 13, 2024	SELL	$92.57 - $107.37 $462,016 - $535,883	-4,991 Reduced 2.28%	213,706 $22.8 Million
Q1 2024 May 06, 2024	BUY	$95.27 - $108.47 $228,457 - $260,111	2,398 Added 1.11%	218,697 $21.2 Million
Q4 2023 Feb 09, 2024	BUY	$92.27 - $101.54 $1.2 Million - $1.32 Million	13,006 Added 6.4%	216,299 $21.8 Million
Q3 2023 Oct 27, 2023	BUY	$94.73 - $105.13 $428,558 - $475,608	4,524 Added 2.28%	203,293 $20.7 Million
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $1.02 Million - $1.15 Million	10,975 Added 5.84%	198,769 $20.1 Million
Q1 2023 May 05, 2023	BUY	$80.03 - $92.81 $32,252 - $37,402	403 Added 0.22%	187,794 $17.3 Million
Q4 2022 Feb 10, 2023	BUY	$75.55 - $92.52 $188,799 - $231,207	2,499 Added 1.35%	187,391 $17 Million
Q3 2022 Nov 01, 2022	BUY	$74.61 - $87.26 $985,896 - $1.15 Million	13,214 Added 7.7%	184,892 $14.1 Million
Q2 2022 Aug 03, 2022	BUY	$80.52 - $93.75 $1.4 Million - $1.63 Million	17,380 Added 11.26%	171,678 $14.5 Million
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $11.5 Million - $13 Million	143,165 Added 1285.95%	154,298 $13.5 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $433,249 - $479,074	5,436 Added 95.42%	11,133 $974,000
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $60,517 - $70,403	740 Added 14.93%	5,697 $466,000
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $3,835 - $4,236	45 Added 0.92%	4,957 $452,000
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $18,203 - $21,466	218 Added 4.64%	4,912 $420,000
Q4 2020 Feb 10, 2021	SELL	$78.07 - $94.43 $48,793 - $59,018	-625 Reduced 11.75%	4,694 $443,000
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $168,058 - $186,186	-2,046 Reduced 27.78%	5,319 $463,000
Q2 2020 Aug 11, 2020	SELL	$80.93 - $91.1 $129,407 - $145,668	-1,599 Reduced 17.84%	7,365 $643,000
Q1 2020 May 12, 2020	BUY	$70.67 - $99.01 $23,109 - $32,376	327 Added 3.79%	8,964 $739,000
Q4 2019 Feb 11, 2020	SELL	$84.35 - $95.37 $79,626 - $90,029	-944 Reduced 9.85%	8,637 $818,000
Q3 2019 Nov 13, 2019	BUY	$85.54 - $94.26 $273,642 - $301,537	3,199 Added 50.13%	9,581 $833,000
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $76,003 - $93,542	1,008 Added 18.76%	6,382 $583,000
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $26,663 - $30,497	354 Added 7.05%	5,374 $517,000
Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $4,787 - $5,331	65 Added 1.31%	5,020 $431,000
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $34,808 - $40,263	520 Added 11.72%	4,955 $427,000
Q2 2018 Aug 01, 2018	BUY	$64.91 - $73.36 $36,609 - $41,375	564 Added 14.57%	4,435 $335,000
Q1 2018 May 16, 2018	BUY	$70.39 - $84.15 $107,344 - $128,328	1,525 Added 65.0%	3,871 $313,000
Q4 2017 Feb 13, 2018	BUY	$72.33 - $77.64 $24,881 - $26,708	344 Added 17.18%	2,346 $197,000
Q3 2017 Nov 08, 2017	SELL	$74.14 - $77.27 $6.8 Million - $7.09 Million	-91,775 Reduced 97.87%	2,002 $172,000
Q2 2017 Aug 15, 2017	BUY	N/A	455 Added 0.49%	93,777 $7.83 Million
Q1 2017 Sep 15, 2017	BUY	N/A	11,666 Added 14.29%	93,322 $6.93 Million
Q4 2016 Sep 15, 2017	BUY	N/A	2,965 Added 3.77%	81,656 $5.95 Million
Q3 2016 Sep 15, 2017	SELL	N/A	-19,622 Reduced 19.96%	78,691 $6.21 Million
Q2 2016 Sep 15, 2017	BUY	N/A	3,621 Added 3.82%	98,313 $8.11 Million
Q1 2016 Sep 15, 2017	BUY	N/A	20,060 Added 26.88%	94,692 $6.86 Million
Q4 2015 Sep 15, 2017	BUY	N/A	74,632	74,632 $6.42 Million

Others Institutions Holding NVS

# of Institutions

1,431

Shares Held

134M

Call Options Held

1.1M

Put Options Held

1.71M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account